Belite Bio, Inc (BLTE)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS07782B1044
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Belite Bio, Inc, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:57. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 13 Aug 2026 08:00 | -0.78 | — | — | — |
| 20 May 2026 06:00 | -0.64 | -0.68 | -5.8% | Miss |
| 02 Mar 2026 06:00 | -0.54 | -0.70 | -30.3% | Miss |
| 10 Nov 2025 08:00 | -0.49 | -0.65 | -32.7% | Miss |
| 11 Aug 2025 06:00 | -0.42 | -0.50 | -19.8% | Miss |
| 14 May 2025 06:00 | -0.36 | -0.45 | -23.3% | Miss |
| 17 Mar 2025 06:00 | -0.31 | -0.32 | -4.1% | Miss |
| 12 Nov 2024 06:00 | -0.30 | -0.28 | +6.7% | Beat |
| 09 Aug 2024 16:00 | -0.26 | -0.31 | -19.2% | Miss |
| 14 May 2024 06:00 | -0.28 | -0.27 | +5.3% | Beat |
| 12 Mar 2024 06:00 | -0.30 | -0.24 | +19.3% | Beat |
| 14 Nov 2023 06:00 | -0.32 | -0.40 | -25.0% | Miss |
| 09 Aug 2023 06:00 | -0.30 | -0.26 | +12.6% | Beat |
| 10 May 2023 19:00 | -0.23 | -0.33 | -43.5% | Miss |
| 31 Mar 2023 16:00 | -0.33 | -0.25 | +24.2% | Beat |
| 03 Nov 2022 20:00 | -0.24 | -0.24 | 0.0% | In line |
| 10 Aug 2022 20:00 | -0.30 | -0.07 | +76.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -77.6M | — | -2.31 | -95.8% | -37.2M |
| 2024 | 0 | — | -36.1M | — | -1.18 | +0.8% | -29.4M |
| 2023 | 0 | — | -31.6M | — | -1.19 | -88.9% | -29.9M |
| 2022 | 0 | — | -12.6M | — | -0.63 | — | -11.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 155.88 | 170.89 | 149.77 | 163.71 | +6.17% | 1,213,437 | |
| 02 Nov 2026 – 06 Nov 2026 | 155.08 | 157.47 | 141.00 | 154.19 | -0.36% | 745,300 | |
| 26 Oct 2026 – 30 Oct 2026 | 149.12 | 156.32 | 142.13 | 154.74 | +5.03% | 685,300 | |
| 19 Oct 2026 – 23 Oct 2026 | 143.46 | 156.88 | 142.94 | 147.33 | +3.19% | 663,500 | |
| 12 Oct 2026 – 16 Oct 2026 | 154.95 | 161.00 | 141.62 | 142.78 | -7.58% | 1,040,800 | |
| 05 Oct 2026 – 09 Oct 2026 | 160.00 | 160.00 | 150.21 | 154.49 | -3.18% | 755,100 | |
| 28 Sep 2026 – 02 Oct 2026 | 166.98 | 172.74 | 159.00 | 159.56 | -4.64% | 839,800 | |
| 21 Sep 2026 – 25 Sep 2026 | 173.00 | 178.44 | 165.56 | 167.33 | -2.12% | 820,900 | |
| 14 Sep 2026 – 18 Sep 2026 | 172.98 | 178.04 | 166.26 | 170.96 | -1.63% | 675,100 | |
| 08 Sep 2026 – 11 Sep 2026 | 192.71 | 198.58 | 171.21 | 173.79 | -10.24% | 1,173,900 | |
| 228 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Belite Bio Q3 EPS $(0.65) Beats $(0.80) Estimate (opens in a new tab) Benzinga · 12 Nov 2026 07:01
- Belite Bio (BLTE) Stock May Trade Above Fair Value On Book Value (opens in a new tab) Simply Wall St. · 10 Nov 2026 06:11
- Belite Bio to Host Webcast on November 12, 2026, to Discuss Third Quarter 2026 Financial Results (opens in a new tab) 05 Nov 2026 13:00
- Belite Bio Stock In Focus After Stargardt Drug Filings In Three Markets (opens in a new tab) Simply Wall St. · 17 Oct 2026 11:13
- Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross (opens in a new tab) Zacks · 09 Sep 2026 14:55
- Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease (opens in a new tab) MarketBeat · 03 Sep 2026 05:01
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 169.96 USD
- Market cap
- 6.8B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow BLTE and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.